|
Mark S. Duxon Ph.D., Director of Business Projects, Neurology Gastrointestinal
CEDD, GlaxoSmithKline Pharmaceuticals
Dr. Mukund Chorghade, President & CSO, Pharmaceutical Sciences, D&O
Pharmachem Inc.
Gianni Gromo, M.D., Head of Discovery Research Basel, F. Hoffman-La Roche
Ross Horsburgh, M.D., Asia-Pacific Regional Medical Director, AstraZeneca
John Gwynne, M.D., Vice President, Clinical Pharmacology, Wyeth
Pharmaceutical
Paul L. Huang, M.D., Ph.D., Associate Professor of Medicine, Harvard Medical
School, Director, Cardiac Metabolic Syndrome Program, Associate Director,
Cardiovascular Research Center, Massachusetts General Hospital
Alan L. Jakimo, Partner, Sidley Austin Brown & Wood LLP
Sundeep Lal, Ph.D., M.B.A., Senior Director, Worldwide Licensing and External
Research, Merck & Company
Robert Maguire, M.D., Vice President Clinical Development and Chief of
Operations, Wyeth Pharmaceuticals
Fidela Moreno, M.D., Senior Director, Global Development Operations, Asia and
Latin America, Amgen Inc.
Ms. Robyn Murphy, Senior Project Manager, R&D Strategic Operations, Amgen
Inc.
Glenn Rice, President and Chief Executive Officer, Bridge Pharmaceuticals
Alpna Seth, Ph.D., Senior Director, Global Sourcing, Biogen Idec
Satish Tripathi, Director, Worldwide Regulatory Strategy, Pfizer Inc.
Bob Ward, Vice President, Commercial Development, NPS Pharmaceuticals
Jeffrey L. Winkelhake, Ph.D., Vice President, International Operations, Sino
Biopharmaceuticals Ltd.
Michael J. Wise, Partner, Perkins Coie
|
